基因治疗

• 龙舟投资完成对基因治疗公司 神拓生物 战略投资 2021-07-19
• Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune 2021-06-30
• Verve Therapeutics Announces Pricing of Initial Public Offering 2021-06-16
• VectorY Raises €31 Million in Seed Financing to Develop Next-Generation Gene Therapies Aimed at Muscular and CNS Disorders 2021-06-15
• G2 Bio Companies Launch with US$200 Million to Develop Transformative Genetic-Based Therapies 2021-05-18
• Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform 2021-05-18
• Capsida Biotherapeutics Debuts with $140 Million of Capital 2021-05-07
• SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics 2021-04-20
• Code Biotherapeutics Launches with $10 Million in Seed Financing to Develop Therapies for Debilitating Genetic Diseases 2021-04-20
• 诺洁贝完成3000万美元A轮融资，全面推进多款基因治疗产品开发 2021-04-15

登录医药魔方官网 查看更多资讯